A Forbes article reporting on the Swedish American Life Science Summit (SALSS) in Stockholm, which gathered global scientists and investors to discuss innovations in healthcare such as robotics, nanotechnology, and cancer research. The article highlights the shift in the pharmaceutical industry towards collaboration with startups and "impact investing" to address chronic diseases in an aging population, featuring insights from various industry leaders.
This document is a program brochure for the Swedish-American Life Science Summit (SALSS) 2012, held in Stockholm from August 22-24, 2012. It lists the organizing committee and senior advisory board, which includes Dr. William A. Haseltine (a known name in Epstein-related files) representing ACCESS Health International. The document also features a list of corporate sponsors and an essay on global demographics and economics by Hans Rosling.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity